General Information of the Compound
| Compound ID |
CP0860286
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4N,13N-dibenzyl-17-cyclopropylmethyl-16-methyl-17-azatetracyclo[7.6.2.02,7.010,15]heptadeca-2(7),3,5,12,14-pentaene-4,13-diamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H37N3
|
||||||||||||||||||
| Molecular Weight |
499.702
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1[C@H]2c3cc(NCc4ccccc4)ccc3C[C@@H](c3ccc(NCc4ccccc4)cc32)N1CC1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H37N3/c1-24-35-32-19-29(36-21-25-8-4-2-5-9-25)15-14-28(32)18-34(38(24)23-27-12-13-27)31-17-16-30(20-33(31)35)37-22-26-10-6-3-7-11-26/h2-11,14-17,19-20,24,27,34-37H,12-13,18,21-23H2,1H3/t24-,34+,35+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YNFRXLJRYSHXDR-WOGOVJIYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor